Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 379

1.

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer.

Williamson SR, Gill AJ, Argani P, Chen YB, Egevad L, Kristiansen G, Grignon DJ, Hes O.

Am J Surg Pathol. 2020 Apr 3. doi: 10.1097/PAS.0000000000001476. [Epub ahead of print]

PMID:
32251007
2.

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers V: Recommendations on the Use of Immunohistochemical and Molecular Biomarkers in Penile Cancer.

Canete-Portillo S, Velazquez EF, Kristiansen G, Egevad L, Grignon D, Chaux A, Cubilla AL.

Am J Surg Pathol. 2020 Mar 31. doi: 10.1097/PAS.0000000000001477. [Epub ahead of print]

PMID:
32235153
3.

Smooth Muscle Hyperplasia of the Testicular Adnexa: A Clinicopathologic Study of 12 Cases.

Alruwaii F, Grignon D, Idrees MT.

Hum Pathol. 2020 Mar 24. pii: S0046-8177(20)30052-6. doi: 10.1016/j.humpath.2020.03.003. [Epub ahead of print]

PMID:
32220606
4.

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: IV: Current and Future Utilization of Molecular-Genetic Tests for Testicular Germ Cell Tumors.

Looijenga LHJ, Van der Kwast TH, Grignon D, Egevad L, Kristiansen G, Kao CS, Idrees MT.

Am J Surg Pathol. 2020 Mar 20. doi: 10.1097/PAS.0000000000001465. [Epub ahead of print]

PMID:
32205480
5.

Report From the International Society of Urological Pathology (ISUP) Consultation Conference On Molecular Pathology Of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer: Progress and Challenges.

Warrick JI, Knowles MA, Yves A, van der Kwast T, Grignon DJ, Kristiansen G, Egevad L, Hartmann A, Cheng L.

Am J Surg Pathol. 2020 Feb 19. doi: 10.1097/PAS.0000000000001453. [Epub ahead of print]

PMID:
32091435
6.

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer.

Lotan TL, Tomlins SA, Bismar TA, Van der Kwast TH, Grignon D, Egevad L, Kristiansen G, Pritchard CC, Rubin MA, Bubendorf L.

Am J Surg Pathol. 2020 Feb 10. doi: 10.1097/PAS.0000000000001450. [Epub ahead of print]

PMID:
32044806
7.

Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.

Ström P, Kartasalo K, Olsson H, Solorzano L, Delahunt B, Berney DM, Bostwick DG, Evans AJ, Grignon DJ, Humphrey PA, Iczkowski KA, Kench JG, Kristiansen G, van der Kwast TH, Leite KRM, McKenney JK, Oxley J, Pan CC, Samaratunga H, Srigley JR, Takahashi H, Tsuzuki T, Varma M, Zhou M, Lindberg J, Lindskog C, Ruusuvuori P, Wählby C, Grönberg H, Rantalainen M, Egevad L, Eklund M.

Lancet Oncol. 2020 Feb;21(2):222-232. doi: 10.1016/S1470-2045(19)30738-7. Epub 2020 Jan 8. Erratum in: Lancet Oncol. 2020 Feb;21(2):e70.

PMID:
31926806
8.

Dataset for the reporting of carcinoma of the bladder-cystectomy, cystoprostatectomy and diverticulectomy specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Compérat E, Srigley JR, Brimo F, Delahunt B, Koch M, Lopez-Beltran A, Reuter V, Samaratunga H, Shanks JH, Tsuzuki T, van der Kwast T, Varma M, Webster F, Grignon D.

Virchows Arch. 2020 Jan 8. doi: 10.1007/s00428-019-02727-1. [Epub ahead of print]

PMID:
31915958
9.

Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists.

Gandhi JS, Smith SC, Paner GP, McKenney JK, Sekhri R, Osunkoya AO, Baras AS, DeMarzo AM, Cheville JC, Rafael JE, Trpkov K, Colecchia M, Ro JY, Montironi R, Menon S, Hes O, Williamson SR, Hirsch MS, Netto GJ, Fine SW, Sirohi D, Kaushal S, Sangoi A, Robinson BD, Kweldam CF, Humphrey PA, Hansel DE, Schultz L, Magi-Galluzzi C, Przybycin CG, Shah RB, Mehra R, Kunju LP, Aron M, Kryvenko ON, Kench JG, Kuroda N, Tavora F, van der Kwast T, Grignon DJ, Epstein JI, Reuter VE, Amin MB.

Am J Surg Pathol. 2019 Dec 23. doi: 10.1097/PAS.0000000000001417. [Epub ahead of print]

PMID:
31876580
10.

Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline.

Eggener SE, Rumble RB, Armstrong AJ, Morgan TM, Crispino T, Cornford P, van der Kwast T, Grignon DJ, Rai AJ, Agarwal N, Klein EA, Den RB, Beltran H.

J Clin Oncol. 2019 Dec 12:JCO1902768. doi: 10.1200/JCO.19.02768. [Epub ahead of print]

PMID:
31829902
11.

Micropapillary urothelial carcinoma of urinary bladder displays immunophenotypic features of luminal and p53-like subtypes and is not a variant of adenocarcinoma.

Yang Y, Kaimakliotis HZ, Williamson SR, Koch MO, Huang K, Barboza MP, Zhang S, Wang M, Idrees MT, Grignon DJ, Eble JN, Baldridge LA, Cheng L.

Urol Oncol. 2019 Nov 15. pii: S1078-1439(19)30419-3. doi: 10.1016/j.urolonc.2019.10.013. [Epub ahead of print]

PMID:
31740332
12.

Dataset for the reporting of urinary tract carcinoma-biopsy and transurethral resection specimen: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Varma M, Srigley JR, Brimo F, Compérat E, Delahunt B, Koch M, Lopez-Beltran A, Reuter V, Samaratunga H, Shanks JH, Tsuzuki T, van der Kwast T, Webster F, Grignon D.

Mod Pathol. 2020 Apr;33(4):700-712. doi: 10.1038/s41379-019-0403-9. Epub 2019 Nov 4.

PMID:
31685965
13.

Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity.

Al-Obaidy KI, Eble JN, Nassiri M, Cheng L, Eldomery MK, Williamson SR, Sakr WA, Gupta N, Hassan O, Idrees MT, Grignon DJ.

Mod Pathol. 2019 Sep 18. doi: 10.1038/s41379-019-0362-1. [Epub ahead of print]

PMID:
31534204
14.

Renal cell tumors with an entrapped papillary component: a collision with predilection for oncocytic tumors.

Williamson SR, Cheng L, Gadde R, Giannico GA, Wasco MJ, Taylor Smith PJ, Gupta NS, Grignon DJ, Jorda M, Kryvenko ON.

Virchows Arch. 2020 Mar;476(3):399-407. doi: 10.1007/s00428-019-02648-z. Epub 2019 Aug 23.

PMID:
31444626
15.

Data Set for the Reporting of Carcinoma of the Renal Pelvis and Ureter-Nephroureterectomy and Ureterectomy Specimens: Recommendations From the International Collaboration on Cancer Reporting (ICCR).

Samaratunga H, Judge M, Delahunt B, Srigley J, Brimo F, Comperat E, Koch M, Lopez-Beltran A, Reuter V, Shanks J, Tsuzuki T, van der Kwast T, Varma M, Grignon D.

Am J Surg Pathol. 2019 Oct;43(10):e1-e12. doi: 10.1097/PAS.0000000000001305.

PMID:
31192862
16.

MYB-NFIB gene fusion in prostatic basal cell carcinoma: clinicopathologic correlates and comparison with basal cell adenoma and florid basal cell hyperplasia.

Magers MJ, Iczkowski KA, Montironi R, Grignon DJ, Zhang S, Williamson SR, Yang X, Wang M, Osunkoya AO, Lopez-Beltran A, Hes O, Eble JN, Cheng L.

Mod Pathol. 2019 Nov;32(11):1666-1674. doi: 10.1038/s41379-019-0297-6. Epub 2019 Jun 12.

PMID:
31189999
17.

Papillary Renal Neoplasm With Reverse Polarity: A Morphologic, Immunohistochemical, and Molecular Study.

Al-Obaidy KI, Eble JN, Cheng L, Williamson SR, Sakr WA, Gupta N, Idrees MT, Grignon DJ.

Am J Surg Pathol. 2019 Aug;43(8):1099-1111. doi: 10.1097/PAS.0000000000001288.

PMID:
31135486
18.

Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients.

Perrino CM, Eble J, Kao CS, Whaley RD, Cheng L, Idrees M, Hashemi-Sadraei N, Monn MF, Kaimakliotis HZ, Bandali E, Grignon D.

Hum Pathol. 2019 Aug;90:27-36. doi: 10.1016/j.humpath.2019.04.012. Epub 2019 May 3.

PMID:
31054897
19.

Dataset for reporting of carcinoma of the urethra (in urethrectomy specimens): recommendations from the International Collaboration on Cancer Reporting (ICCR).

Shanks JH, Srigley JR, Brimo F, Comperat E, Delahunt B, Koch M, Lopez-Beltran A, Reuter VE, Samaratunga H, Tsuzuki T, van der Kwast T, Varma M, Grignon D.

Histopathology. 2019 Oct;75(4):453-467. doi: 10.1111/his.13877. Epub 2019 Jul 2. Review.

PMID:
31009090
20.

DOG1 immunohistochemical staining of testicular biopsies is a reliable tool for objective assessment of infertility.

Salama R, Al-Obaidy KI, Perrino CM, Grignon DJ, Ulbright TM, Idrees MT.

Ann Diagn Pathol. 2019 Jun;40:18-22. doi: 10.1016/j.anndiagpath.2019.02.015. Epub 2019 Feb 20.

PMID:
30849695
21.

Primary Renal Synovial Sarcomas: PAX 8 Immunostaining and Unusual Molecular Findings.

Rose L, Grignon D, Cheng L, Fan R, Zhang S, Alruwaii F, Chen S.

Appl Immunohistochem Mol Morphol. 2020 Mar;28(3):221-228. doi: 10.1097/PAI.0000000000000736.

PMID:
30789354
22.

Adenocarcinoma of the Rete Testis: Clinicopathologic and Immunohistochemical Characterization of 6 Cases and Review of the Literature.

Al-Obaidy KI, Idrees MT, Grignon DJ, Ulbright TM.

Am J Surg Pathol. 2019 May;43(5):670-681. doi: 10.1097/PAS.0000000000001219. Review.

PMID:
30676333
23.

Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202.

Dignam JJ, Hamstra DA, Lepor H, Grignon D, Brereton H, Currey A, Rosenthal S, Zeitzer KL, Venkatesan VM, Horwitz EM, Pisansky TM, Sandler HM.

J Clin Oncol. 2019 Jan 20;37(3):213-221. doi: 10.1200/JCO.18.00154. Epub 2018 Dec 7.

24.

SIU-ICUD on bladder cancer: pathology.

Compérat E, Babjuk M, Algaba F, Amin M, Brimo F, Grignon D, Hansel D, Hes O, Malavaud B, Reuter V, van der Kwast T.

World J Urol. 2019 Jan;37(1):41-50. doi: 10.1007/s00345-018-2466-5. Epub 2018 Sep 14.

PMID:
30218308
25.

Immunohistochemical characteristics of renomedullary interstitial cell tumor: a study of 41 tumors with emphasis on differential diagnosis of mesenchymal neoplasms.

Lu Z, Al-Obaidy K, Cheng L, Perry KD, Grignon DJ, Williamson SR.

Hum Pathol. 2018 Dec;82:46-50. doi: 10.1016/j.humpath.2018.07.010. Epub 2018 Jul 18.

PMID:
30031100
26.

Commentary on "Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy."

Thomas DE, Kaimakliotis HZ, Rice KR, Pereira JA, Johnston P, Moore ML, Reed A, Cregar DM, Franklin C, Loman RL, Koch MO, Bihrle R, Foster RS, Masterson TA, Gardner TA, Sundaram CP, Powell CR, Beck S, Grignon DJ, Cheng L, Albany C, Hahn NM.

Urol Oncol. 2018 Jul;36(7):345. doi: 10.1016/j.urolonc.2018.05.003. Epub 2018 Jun 5.

PMID:
29880459
27.

Challenges in Pathologic Staging of Renal Cell Carcinoma: A Study of Interobserver Variability Among Urologic Pathologists.

Williamson SR, Rao P, Hes O, Epstein JI, Smith SC, Picken MM, Zhou M, Tretiakova MS, Tickoo SK, Chen YB, Reuter VE, Fleming S, Maclean FM, Gupta NS, Kuroda N, Delahunt B, Mehra R, Przybycin CG, Cheng L, Eble JN, Grignon DJ, Moch H, Lopez JI, Kunju LP, Tamboli P, Srigley JR, Amin MB, Martignoni G, Hirsch MS, Bonsib SM, Trpkov K.

Am J Surg Pathol. 2018 Sep;42(9):1253-1261. doi: 10.1097/PAS.0000000000001087.

PMID:
29878933
28.

Utility of Pathology Imagebase for standardisation of prostate cancer grading.

Egevad L, Delahunt B, Berney DM, Bostwick DG, Cheville J, Comperat E, Evans AJ, Fine SW, Grignon DJ, Humphrey PA, Hörnblad J, Iczkowski KA, Kench JG, Kristiansen G, Leite KRM, Magi-Galluzzi C, McKenney JK, Oxley J, Pan CC, Samaratunga H, Srigley JR, Takahashi H, True LD, Tsuzuki T, van der Kwast T, Varma M, Zhou M, Clements M.

Histopathology. 2018 Jul;73(1):8-18. doi: 10.1111/his.13471. Epub 2018 Mar 5.

PMID:
29359484
29.

Prostate cancer reporting and staging: needle biopsy and radical prostatectomy specimens.

Grignon DJ.

Mod Pathol. 2018 Jan;31(S1):S96-109. doi: 10.1038/modpathol.2017.167. Review.

30.

Renal cell carcinoma with angioleiomyoma-like stroma and clear cell papillary renal cell carcinoma: exploring SDHB protein immunohistochemistry and the relationship to tuberous sclerosis complex.

Williamson SR, Hornick JL, Eble JN, Gupta NS, Rogers CG, True L, Grignon DJ, Cheng L.

Hum Pathol. 2018 May;75:10-15. doi: 10.1016/j.humpath.2017.11.013. Epub 2017 Nov 24.

PMID:
29180251
31.

Reply to Chou et al 'Do significant TFE3 gene rearrangements occur in succinate dehydrogenase deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution' Mod Pathol 2017; in press.

Williamson SR, Grignon DJ, Calió A, Stohr BA, Eble JN, Cheng L.

Mod Pathol. 2017 Oct;30(10):1509-1511. doi: 10.1038/modpathol.2017.84. No abstract available.

32.

Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation.

Caliò A, Eble JN, Hes O, Martignoni G, Harari SE, Williamson SR, Brunelli M, Osunkoya AO, Wang L, Comperat E, Lopez-Beltran A, Wang M, Zhang S, Curless KL, Post KM, Chang HY, Luchini C, Baldrige LA, MacLennan GT, Montironi R, Grignon DJ, Cheng L.

Oncotarget. 2016 Aug 8;8(33):54096-54105. doi: 10.18632/oncotarget.11117. eCollection 2017 Aug 15.

33.

Morphological spectrum of renal cell carcinoma, unclassified: an analysis of 136 cases.

Perrino CM, Grignon DJ, Williamson SR, Idrees MT, Eble JN, Cheng L.

Histopathology. 2018 Jan;72(2):305-319. doi: 10.1111/his.13362. Epub 2017 Oct 24.

PMID:
28833389
34.

Preservation of truncal genomic alterations in clear cell and papillary renal cell carcinomas with sarcomatoid features: An intra- and intertumoral, multifocal fluorescence in situ hybridization analysis reveals limited genetic heterogeneity.

Sanfrancesco JM, Eble JN, Grignon DJ, Wang M, Zhang S, Sundaram CP, Idrees MT, Pili R, Kouba E, Cheng L.

Mol Carcinog. 2017 Nov;56(11):2527-2537. doi: 10.1002/mc.22699. Epub 2017 Aug 3.

PMID:
28667776
35.

Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens.

Harari SE, Sassoon DJ, Priemer DS, Jacob JM, Eble JN, Caliò A, Grignon DJ, Idrees M, Albany C, Masterson TA, Hanna NH, Foster RS, Ulbright TM, Einhorn LH, Cheng L.

Urol Oncol. 2017 Oct;35(10):605.e9-605.e16. doi: 10.1016/j.urolonc.2017.05.018. Epub 2017 Jun 21. Review.

PMID:
28647396
36.

Variant morphology in upper urinary tract urothelial carcinoma: a 14-year case series of biopsy and resection specimens.

Hayashi H, Mann S, Kao CS, Grignon D, Idrees MT.

Hum Pathol. 2017 Jul;65:209-216. doi: 10.1016/j.humpath.2017.05.001. Epub 2017 May 12.

37.

Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202.

Lawton CAF, Lin X, Hanks GE, Lepor H, Grignon DJ, Brereton HD, Bedi M, Rosenthal SA, Zeitzer KL, Venkatesan VM, Horwitz EM, Pisansky TM, Kim H, Parliament MB, Rabinovitch R, Roach M 3rd, Kwok Y, Dignam JJ, Sandler HM.

Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):296-303. doi: 10.1016/j.ijrobp.2017.02.004. Epub 2017 Feb 12.

38.

Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists.

Williamson SR, Gadde R, Trpkov K, Hirsch MS, Srigley JR, Reuter VE, Cheng L, Kunju LP, Barod R, Rogers CG, Delahunt B, Hes O, Eble JN, Zhou M, McKenney JK, Martignoni G, Fleming S, Grignon DJ, Moch H, Gupta NS.

Hum Pathol. 2017 May;63:149-156. doi: 10.1016/j.humpath.2017.03.004. Epub 2017 Mar 14.

39.

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.

Shipley WU, Seiferheld W, Lukka HR, Major PP, Heney NM, Grignon DJ, Sartor O, Patel MP, Bahary JP, Zietman AL, Pisansky TM, Zeitzer KL, Lawton CA, Feng FY, Lovett RD, Balogh AG, Souhami L, Rosenthal SA, Kerlin KJ, Dignam JJ, Pugh SL, Sandler HM; NRG Oncology RTOG.

N Engl J Med. 2017 Feb 2;376(5):417-428. doi: 10.1056/NEJMoa1607529.

40.

Prostate Cancer Grading: A Decade After the 2005 Modified Gleason Grading System.

Delahunt B, Grignon DJ, Samaratunga H, Srigley JR, Leite KR, Kristiansen G, Evans AJ, Kench JG, Egevad L.

Arch Pathol Lab Med. 2017 Feb;141(2):182-183. doi: 10.5858/arpa.2016-0300-LE. No abstract available.

PMID:
28134585
41.

Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202.

Mirhadi AJ, Zhang Q, Hanks GE, Lepor H, Grignon DJ, Peters CA, Rosenthal SA, Zeitzer K, Radwan JS, Lawton C, Parliament MB, Reznik RS, Sandler HM.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):511-515. doi: 10.1016/j.ijrobp.2016.11.002. Epub 2016 Nov 8.

42.

Prognostic Effect of Carcinoma In Situ in Muscle-invasive Urothelial Carcinoma Patients Receiving Neoadjuvant Chemotherapy.

Thomas DE, Kaimakliotis HZ, Rice KR, Pereira JA, Johnston P, Moore ML, Reed A, Cregar DM, Franklin C, Loman RL, Koch MO, Bihrle R, Foster RS, Masterson TA, Gardner TA, Sundaram CP, Powell CR, Beck SDW, Grignon DJ, Cheng L, Albany C, Hahn NM.

Clin Genitourin Cancer. 2017 Aug;15(4):479-486. doi: 10.1016/j.clgc.2016.11.009. Epub 2016 Nov 30.

43.

Renal Cell Carcinoma With Chromosome 6p Amplification Including the TFEB Gene: A Novel Mechanism of Tumor Pathogenesis?

Williamson SR, Grignon DJ, Cheng L, Favazza L, Gondim DD, Carskadon S, Gupta NS, Chitale DA, Kalyana-Sundaram S, Palanisamy N.

Am J Surg Pathol. 2017 Mar;41(3):287-298. doi: 10.1097/PAS.0000000000000776.

PMID:
28009604
44.

Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation.

Calió A, Grignon DJ, Stohr BA, Williamson SR, Eble JN, Cheng L.

Mod Pathol. 2017 Mar;30(3):407-415. doi: 10.1038/modpathol.2016.200. Epub 2016 Dec 2.

45.

Cystic Nephroma in Adults: A Clinicopathologic Study of 46 Cases.

Caliò A, Eble JN, Grignon DJ, Delahunt B.

Am J Surg Pathol. 2016 Dec;40(12):1591-1600.

PMID:
27831959
46.

Solitary fibrous tumour of the genitourinary tract: a clinicopathological study of 11 cases and their association with the NAB2-STAT6 fusion gene.

Kouba E, Simper NB, Chen S, Williamson SR, Grignon DJ, Eble JN, MacLennan GT, Montironi R, Lopez-Beltran A, Osunkoya AO, Zhang S, Wang M, Wang L, Tran T, Emerson RE, Baldrige LA, Monn MF, Linos K, Cheng L.

J Clin Pathol. 2017 Jun;70(6):508-514. doi: 10.1136/jclinpath-2016-204088. Epub 2016 Oct 31.

47.

High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatment.

Kouba EJ, Eble JN, Simper N, Grignon DJ, Wang M, Zhang S, Wang L, Martignoni G, Williamson SR, Brunelli M, Luchini C, Calió A, Cheng L.

Mod Pathol. 2016 Nov;29(11):1347-1357. doi: 10.1038/modpathol.2016.133. Epub 2016 Jul 29.

48.

Mixed Epithelial and Stromal Tumor of the Kidney: A Clinicopathologic Study of 53 Cases.

Caliò A, Eble JN, Grignon DJ, Delahunt B.

Am J Surg Pathol. 2016 Nov;40(11):1538-1549.

PMID:
27635943
49.

Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms.

Bonsib SM, Boils C, Gokden N, Grignon D, Gu X, Higgins JP, Leroy X, McKenney JK, Nasr SH, Phillips C, Sangoi AR, Wilson J, Zhang PL.

Pathol Res Pract. 2016 Nov;212(11):972-979. doi: 10.1016/j.prp.2016.04.005. Epub 2016 Apr 30.

50.

Evidence of a dual histogenetic pathway of sacrococcygeal teratomas.

Emerson RE, Kao CS, Eble JN, Grignon DJ, Wang M, Zhang S, Wang X, Fan R, Masterson TA, Roth LM, Cheng L.

Histopathology. 2017 Jan;70(2):290-300. doi: 10.1111/his.13062. Epub 2016 Oct 10.

Supplemental Content

Loading ...
Support Center